RayKnowChina Research Map
Shortlist0

Not yet recruitingStomach cancerPhase not stated

Registered title, quoted from ClinicalTrials.gov

Multi-center Prospective Validation of Real-Time AI-EGGIM System

An open trial on stomach cancer, registered on ClinicalTrials.gov. Led by Qilu Hospital of Shandong University; 0 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

Read the record on ClinicalTrials.gov

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 1

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Lead sponsorQilu Hospital of Shandong University山东大学齐鲁医院JinanHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT07915843, read on 8 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

  • patients undergoing upper gastrointestinal endoscopy who met at least one of the following criteria: (i) aged 40-75 years; or (ii) had a history of H. pylori infection and/or known premalignant gastric lesions (e.g., atrophic gastritis and IM)
  • patients who voluntarily sign the informed consent form

Exclusion Criteria:

  • patients with severe cardiac, cerebral, pulmonary, or renal dysfunction or psychiatric disorders who cannot receive upper gastrointestinal endoscopy
  • patients with previous surgical procedures on the stomach
  • patients with upper gastrointestinal cancer
  • patients with contraindication to gastric mucosal biopsy

Quoted from ClinicalTrials.gov, NCT07915843, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT07915843, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT07915843